vTv Therapeutics Inc. Net Change in Cash
vTv Therapeutics Inc. (VTVT) reported Net Change in Cash of -$2.29 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-06
- vTv Therapeutics Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was $9.15M.
- vTv Therapeutics Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was -$5.69M, a 113.28% decline year-over-year.
- vTv Therapeutics Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was $42.81M, a 544.71% increase year-over-year.
- vTv Therapeutics Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was $6.64M.
- vTv Therapeutics Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was $52.19M, a 91.16% increase from fiscal 2024.
- vTv Therapeutics Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was $27.30M.
- vTv Therapeutics Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$2.68M.
- vTv Therapeutics Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$1.29M, a 116.81% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.29M 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | $9.15M 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | $52.19M 10-K · filed 2026-03-10 | |||
| 2025-09-30 | $61.76M 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | -$10.82M 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | -$5.69M 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | $27.30M 10-K · filed 2026-03-10 | |||
| 2024-09-30 | $32.13M 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | $36.08M 10-Q · filed 2025-08-12 | |||
| 2024-03-31 | $42.81M 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | -$2.68M 10-K · filed 2026-03-10 | |||
| 2023-09-30 | -$3.89M 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | $473.00K 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | $6.64M 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$1.29M 10-K · filed 2025-03-20 | |||
| 2022-09-30 | $1.92M 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | $4.45M 10-Q · filed 2023-08-11 | |||
| 2022-03-31 | -$1.28M 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $7.67M 10-K · filed 2024-03-13 | |||
| 2021-09-30 | $13.82M 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | $5.09M 10-Q · filed 2022-08-15 | |||
| 2021-03-31 | $2.70M 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $1.47M 10-K · filed 2023-03-06 | |||
| 2020-09-30 | -$2.45M 10-Q · filed 2021-11-09 | |||
| 2020-06-30 | $2.12M 10-Q · filed 2021-08-04 | |||
| 2020-03-31 | -$1.37M 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | $94.00K 10-K · filed 2022-03-29 | |||
| 2019-09-30 | $753.00K 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | -$221.00K 10-Q · filed 2020-08-03 | |||
| 2019-03-31 | $3.28M 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | -$10.24M 10-K · filed 2021-02-24 | |||
| 2018-09-30 | -$8.15M 10-Q · filed 2019-10-30 | |||
| 2018-06-30 | -$10.76M 10-Q · filed 2019-07-31 | |||
| 2018-03-31 | -$5.38M 10-Q · filed 2019-05-01 | |||
| 2017-12-31 | -$37.09M 10-K · filed 2020-02-21 | |||
| 2017-09-30 | -$30.74M 10-Q · filed 2018-11-08 | |||
| 2017-06-30 | -$18.99M 10-Q · filed 2018-08-03 | |||
| 2016-12-31 | -$36.50M 10-K · filed 2019-02-26 |